FTC’s Ban of Noncompete Agreements Halted
With the rule recently struck down by a Texas court, how should employers, including labs, handle such agreements going forward?
Essential
Subscribe today for access to
Articles and Reports
Six Sigma Can Help Monitor New CLIA Proficiency Testing Changes
A PT update went into effect on January 1, focusing on revised acceptance limits, among other modifications
ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
In Brief: OIG Opens Second Avenue for Anti-Kickback Statute Revisions
...
Already a member? Log in here
FDA Targets Sale of IVD Reagents without Premarket Approval
...
Already a member? Log in here
By the Numbers: Improper Medicare Payments Hit 10-Year Low
...
Already a member? Log in here
ACA: Still Here Today but for How Much Longer?
...
Already a member? Log in here
PAMA: The New LAB Act Buys Labs One Year of Price Reporting Relief
...
Already a member? Log in here
Texas Health System Fined $431K for Falsely Billing Genetic Tests
...
Already a member? Log in here
Genetic Testing: New Medicare Early NGS Cancer Test Coverage Policy Is Less than Meets the Eye
For Myriad Genetics, Foundation Medicine and other manufacturers of next-generation sequencing (NGS)-based test panels for early-stage cancer risk assessment, the recent announcement of CMS’ decision to provide limited Medicare coverage
Enforcement Trends: Increase in OIG Fraud Recoveries Belies Continued Decline in Enforcement Actions
OIG fraud recovery has been a solid growth business for nearly two decades. So, when the agency announced a decline in FY 2018 recovery figures, it was more than a bit surprising. But things got back to normal this year, as far as
Federal Court Dismisses Whistleblowers’ Urine Drug Test False Billing Claim
...
Already a member? Log in here
OIG Work Plan: Agency to Focus on Vaccine Adverse Event Reporting
...
Already a member? Log in here